Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis

BACKGROUND: To assess the role of drugs used in dual therapy (DT), as cART simplification, over the risk of treatment failure. MATERIALS AND METHODS: Patients starting DT regimen composed by a boosted protease inhibitor (PI/r): darunavir (DRV/r), lopinavir (LPVr) or atazanavir (ATV/r) plus a second...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaccarelli, Mauro, Fabbiani, Massimiliano, Pinnetti, Carmela, Borghi, Vanni, Giannetti, Alberto, Sterrantino, Gaetana, Lorenzini, Patrizia, Latini, Alessandra, Loiacono, Laura, Colafigli, Manuela, Ammassari, Adriana, D'Ettorre, Gabriella, Plazzi, Maddalena, Di Giambenedetto, Simona, Antinori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P270
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225349/
https://www.ncbi.nlm.nih.gov/pubmed/25397546
http://dx.doi.org/10.7448/IAS.17.4.19802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225349/
https://www.ncbi.nlm.nih.gov/pubmed/25397546
http://dx.doi.org/10.7448/IAS.17.4.19802

Ejemplares similares